SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-22-000010
Filing Date
2022-01-05
Accepted
2022-01-05 14:41:31
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.FOREST BASKETTNEA 14 GP, LTDNEA PARTNERS 14, L.P.PATRICK J. KERINSPETER W. SONSINISCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 14, L.P. -- LUMOS PHARMA, INC. 13D/A1E nea14-lumos_18577.htm SC 13D/A 100607
  Complete submission text file 0001072613-22-000010.txt   102472
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Subject) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86491 | Film No.: 22510670
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 14, L.P. (Filed by) CIK: 0001544328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A